When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...

AbbVie and RemeGen are collaborating on RC148, a novel PD-1/VEGF-targeted bispecific antibody already being developed as a ...

AbbVie & RemeGen enter exclusive licensing agreement to develop novel bispecific antibody for advanced solid tumours: North Chicago, Illinois Tuesday, January 13, 2026, 14:00 Hrs ...

US pharma major AbbVie and China’s RemeGen today announced an exclusive licensing agreement for the development, ...

A recent study links chemotherapy to impaired ovarian function and fertility through oxidative damage to ovarian follicles.

A ₹3.5 crore Madhya Pradesh-funded study on cow dung and urine as cancer treatment raises questions over scientific validity, ...

AbbVie (NYSE: ABBV) and RemeGen today announced an exclusive licensing agreement for the development, manufacturing and commercialization of RC148, a novel investigational Programmed Cell Death-1 ...

Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

The deal is the second Chinese oncology pact in as many weeks for AbbVie, which also committed $175 million for a ...

Chronic inflammation resulting from obesity is considered dangerous and leaves many confused about whether this actually ...